Fernando Kreutz has 25+ years of experience in cancer Immunotherapy. He shares a vast knowledge in clinical R&D in the pharma industry, having successfully registered patents for solid tumors in prostate cancer, and opening ground for the expansion of his technology throughout all solid tumors. Dr. Kreutz earned a Ph.D. in - Pharmacy and Pharmaceutical Science from the University of Alberta.